Vaccines
30 January 2023
CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs18 January 2023
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial16 January 2023
Intravacc Announces Favorable Preclinical Data for its Candidate Intranasal Gonorrhea Vaccine Avacc 11®13 January 2023
Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines10 January 2023
Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine6 January 2023
CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs4 January 2023
Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-0122 December 2022
BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT16321 December 2022
VidPrevtyn Beta COVID-19 booster vaccine, developed by Sanofi and GSK, approved for use in Great Britain20 December 2022
BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors15 December 2022
Everest Medicines Announces New mRNA Rabies Vaccine Program and Achievement of Preclinical Proof-of-Concept Milestone12 December 2022
Amphera Announces Clinical Updates of MesoPher Cell Therapy9 December 2022
PDC*line Pharma Presents First Immunological Results From Phase I/II Trial With PDC*lung01 at ESMO-IO 20228 December 2022
Takeda’s QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union5 December 2022
Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate1 December 2022
AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further DevelopmentNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports